ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,162Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 2588

$1.1M Total Retail Price of All Prescriptions

Rank: 71 out of 2588

593 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

11% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,375 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 619 593 1 2
AMLODIPINE BESYLATE 400 379 2 4
FUROSEMIDE 385 375 3 5
WARFARIN SODIUM 376 355 4 10
LISINOPRIL 339 314 5 3
BYSTOLIC 330 323 6 110
PRAVASTATIN SODIUM 316 300 7 16
ATORVASTATIN CALCIUM 305 276 8 11
OMEPRAZOLE 281 275 9 6
HYDROCODONE-ACETAMINOPHEN 228 161 S3 10 7
NAMENDA 223 223 11 32
CRESTOR 209 196 12 25
HYDROCHLOROTHIAZIDE 208 191 13 13
METOPROLOL TARTRATE 200 193 14 9
METOPROLOL SUCCINATE 190 178 15 12
SIMVASTATIN 186 175 16 1
LOSARTAN POTASSIUM 152 147 17 17
ALENDRONATE SODIUM 143 141 18 21
SPIRONOLACTONE 142 134 19 58
METFORMIN HCL 140 138 20 8
METFORMIN HCL ER 138 137 21 67
POTASSIUM CHLORIDE 129 127 22 15
DIOVAN 117 96 23 29
TRAMADOL HCL 115 107 24 19
ZOLPIDEM TARTRATE 114 99 25 24
SPIRIVA 111 99 26 56
DICLOFENAC SODIUM 106 96 27 124
CITALOPRAM HBR 105 100 28 27
GLIMEPIRIDE 102 100 29 39
CARVEDILOL 101 99 30 20
DIGOXIN 100 97 31 38
NEXIUM 97 85 32 41
SERTRALINE HCL 93 82 33 26
CLOPIDOGREL 92 84 34 30
RANITIDINE HCL 89 85 35 37
PREDNISONE 88 87 36 42
GABAPENTIN 86 73 37 18
DIOVAN HCT 84 81 38 72
MELOXICAM 84 78 38 51
ACTONEL 82 81 40 184
ALLOPURINOL 81 78 41 33
CARBIDOPA-LEVODOPA 81 81 41 83
ADVAIR DISKUS 78 63 43 48
PANTOPRAZOLE SODIUM 78 76 43 28
NIASPAN 77 74 45 115
EXELON 75 75 46 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 69 47 35
MIRTAZAPINE 72 72 48 63
FLUTICASONE PROPIONATE 70 66 49 40
TAMSULOSIN HCL 69 68 50 23
IRBESARTAN 68 64 51 307
PLAVIX 68 60 51 43
DONEPEZIL HCL 68 68 51 22
INDAPAMIDE 66 66 54 189
ONGLYZA 65 65 55 248
SYMBICORT 62 62 56 129
AMIODARONE HCL 59 59 57 156
CELEBREX 58 45 58 99
EXFORGE 57 57 59 209
BENICAR 56 56 60 143
AZITHROMYCIN 56 51 60 45
FELODIPINE ER 55 55 62 108
ROPINIROLE HCL 53 53 63 113
TRAZODONE HCL 52 52 64 61
ZETIA 52 49 64 69
PRADAXA 50 50 66 207
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.